Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Ra Capital Management, L.P. reported a 9.90% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Fulcrum Therapeutics, Inc., 6,649,973 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 6,649,973
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 6,649,973 |
| Peter Kolchinsky | 9.90% | 6,649,973 |
| Rajeev Shah | 9.90% | 6,649,973 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 6,649,973 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Ra Capital Management, L.P.
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Dec 10, 2025
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026